| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $58M |
Buys | $111,250 | 1 | 33 |
Sells | $316,777 | 2 | 67 |
| Privitera Salvatore | Chief Technical Officer | 1 | $111,250 | 0 | $0 | $111,250 |
| Yuen Maggie | director | 0 | $0 | 1 | $84,245 | $-84,245 |
| Prange Karen | director | 0 | $0 | 1 | $232,532 | $-232,532 |
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Over the last 12 months, insiders at AtriCure, Inc. have bought $111,250 and sold $316,777 worth of AtriCure, Inc. stock.
On average, over the past 5 years, insiders at AtriCure, Inc. have bought $307,263 and sold $8.91M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Privitera Salvatore (Chief Technical Officer) — $111,250.
The last purchase of 5,000 shares for transaction amount of $111,250 was made by Privitera Salvatore (Chief Technical Officer) on 2024‑05‑30.
| 2025-03-05 | Sale | Prange Karen | director | 6,100 0.0124% | $38.12 | $232,532 | -13.87% | |
| 2024-08-15 | Sale | Yuen Maggie | director | 3,500 0.0082% | $24.07 | $84,245 | +36.57% | |
| 2024-05-30 | Privitera Salvatore | Chief Technical Officer | 5,000 0.0103% | $22.25 | $111,250 | +38.01% | ||
| 2024-05-01 | Sale | Noznesky Justin J | Chief Mktg & Strategy Officer | 1,500 0.003% | $24.09 | $36,135 | +18.50% | |
| 2024-04-01 | Sale | Noznesky Justin J | Chief Mktg & Strategy Officer | 1,500 0.0033% | $30.39 | $45,585 | -3.99% | |
| 2024-03-18 | Sale | Dahlquist Karl S. | Chief Legal Officer | 1,885 0.004% | $32.16 | $60,622 | -12.70% | |
| 2024-03-12 | Sale | Noznesky Justin J | Chief Mktg & Strategy Officer | 1,500 0.0033% | $36.72 | $55,080 | -20.21% | |
| 2024-03-05 | Sale | Dahlquist Karl S. | Chief Legal Officer | 8,231 0.0172% | $37.36 | $307,510 | -26.19% | |
| 2023-11-01 | Sale | Dahlquist Karl S. | Chief Legal Officer | 1,248 0.0026% | $34.43 | $42,969 | -20.14% | |
| 2023-07-26 | Sale | Dahlquist Karl S. | Chief Legal Officer | 3,417 0.008% | $57.09 | $195,077 | -41.15% | |
| 2023-06-08 | Sale | Prange Karen | director | 713 0.0015% | $47.89 | $34,146 | -25.70% | |
| 2023-06-06 | Sale | Dahlquist Karl S. | Chief Legal Officer | 1,422 0.003% | $47.03 | $66,877 | -26.28% | |
| 2023-05-26 | Sale | Yuen Maggie | director | 4,313 0.0094% | $47.04 | $202,884 | -22.53% | |
| 2023-05-01 | Sale | Dahlquist Karl S. | Chief Legal Officer | 4,417 0.0095% | $44.83 | $198,014 | -16.89% | |
| 2022-05-13 | Sale | Austin Tonya | Chief Human Resources Officer | 3,203 0.007% | $42.69 | $136,736 | -0.84% | |
| 2022-04-08 | Sale | Austin Tonya | Chief Human Resources Officer | 282 0.0006% | $61.59 | $17,368 | -30.04% | |
| 2022-03-04 | Sale | Austin Tonya | Chief Human Resources Officer | 1,409 0.0031% | $67.66 | $95,333 | -35.60% | |
| 2022-03-02 | Sale | Austin Tonya | Chief Human Resources Officer | 3,259 0.0071% | $70.40 | $229,434 | -38.89% | |
| 2022-02-11 | Sale | Austin Tonya | Chief Human Resources Officer | 2,490 0.0057% | $67.97 | $169,245 | -32.51% | |
| 2022-01-14 | Sale | Austin Tonya | Chief Human Resources Officer | 2,719 0.006% | $66.11 | $179,753 | -30.89% |
| Privitera Salvatore | Chief Technical Officer | 103290 0.2086% | $3.52M | 1 | 11 | |
| Prange Karen | director | 17828 0.036% | $607,043.40 | 0 | 2 | |
| Yuen Maggie | director | 8970 0.0181% | $305,428.50 | 0 | 2 | |
| Discovery Group I, LLC | 10 percent owner | 1621334 3.2751% | $55.21M | 47 | 25 | +15.37% |
| CARREL MICHAEL H | President, CEO, & Director | 504795 1.0197% | $17.19M | 0 | 25 | |
| ROBARDS KAREN P | director | 288328 0.5824% | $9.82M | 23 | 3 | +76.77% |
| Wrubel Lee R | director | 285717 0.5771% | $9.73M | 0 | 21 | |
| HARRISON DONALD C | director | 198741 0.4015% | $6.77M | 0 | 2 | |
| Drachman David J | President and CEO | 146000 0.2949% | $4.97M | 4 | 15 | <0.0001% |
| Wade M. Andrew | CFO | 145120 0.2931% | $4.94M | 0 | 9 | |
| Piton Julie A | VP Fin & Admin & CFO | 85922 0.1736% | $2.93M | 1 | 2 | <0.0001% |
| Collar Mark A | director | 77307 0.1562% | $2.63M | 2 | 10 | <0.0001% |
| Noznesky Justin J | Chief Mktg & Strategy Officer | 71284 0.144% | $2.43M | 0 | 15 | |
| Wirick Angela L | Chief Financial Officer | 70146 0.1417% | $2.39M | 0 | 2 | |
| LUX ANDREW L | SVP, Ops & Quality | 65589 0.1325% | $2.23M | 1 | 2 | +17.91% |
| Seith Douglas J | Chief Operating Officer | 64711 0.1307% | $2.2M | 2 | 15 | +43.56% |
| Hooven Michael D | director | 57049 0.1152% | $1.94M | 7 | 8 | <0.0001% |
| Lucky James L | VP, Clinical, Regulatory & QS | 51250 0.1035% | $1.75M | 0 | 11 | |
| Dahlquist Karl S. | Chief Legal Officer | 50954 0.1029% | $1.73M | 0 | 7 | |
| Drake Scott William | director | 41036 0.0829% | $1.4M | 2 | 2 | +73.02% |
| JOHNSTON RICHARD M | director | 34727 0.0701% | $1.18M | 1 | 21 | +13.46% |
| Lanning Mark R | director | 25000 0.0505% | $851,250.00 | 3 | 0 | +43.44% |
| Preiss Frederick | Vice President Operations | 24000 0.0485% | $817,200.00 | 0 | 4 | |
| Krell Elizabeth D | director | 19967 0.0403% | $679,876.35 | 1 | 12 | <0.0001% |
| Austin Tonya | Chief Human Resources Officer | 17621 0.0356% | $599,995.05 | 0 | 13 | |
| Doraiswamy Vinayak | Chief Scientific Officer | 16875 0.0341% | $574,593.75 | 0 | 1 | |
| GROVES REGINA E | director | 16194 0.0327% | $551,405.70 | 3 | 3 | +38.8% |
| WEHRWEIN SVEN | director | 12686 0.0256% | $431,958.30 | 0 | 1 | |
| JOHNSON B KRISTINE | director | 10969 0.0222% | $373,494.45 | 1 | 0 | +27.76% |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10 percent owner | 9858 0.0199% | $335,664.90 | 0 | 3 | |
| Walsh Richard S | Vice President; Sales | 1750 0.0035% | $59,587.50 | 2 | 0 | <0.0001% |
| Increased Positions | 118 | +51.75% | 7M | +14.46% |
| Decreased Positions | 93 | -40.79% | 4M | -7.65% |
| New Positions | 42 | New | 3M | New |
| Sold Out Positions | 29 | Sold Out | 828,008 | Sold Out |
| Total Postitions | 253 | +10.96% | 50M | +6.81% |
| Vanguard Group Inc | $139,689.00 | 9.31% | 4.65M | -6,576 | -0.14% | 2024-12-31 |
| Blackrock, Inc. | $126,813.00 | 8.45% | 4.22M | -86,979 | -2.02% | 2025-03-31 |
| Alliancebernstein L.P. | $115,140.00 | 7.67% | 3.84M | -136,999 | -3.45% | 2024-12-31 |
| Hood River Capital Management Llc | $87,770.00 | 5.85% | 2.92M | +93,131 | +3.29% | 2024-12-31 |
| Champlain Investment Partners, Llc | $75,909.00 | 5.06% | 2.53M | -262,144 | -9.39% | 2024-12-31 |
| Macquarie Group Ltd | $71,304.00 | 4.75% | 2.38M | -9,583 | -0.4% | 2024-12-31 |
| First Light Asset Management, Llc | $59,116.00 | 3.94% | 1.97M | +103,685 | +5.56% | 2024-12-31 |
| State Street Corp | $40,432.00 | 2.69% | 1.35M | +1,963 | +0.15% | 2024-12-31 |
| Geode Capital Management, Llc | $34,554.00 | 2.3% | 1.15M | -1,579 | -0.14% | 2024-12-31 |
| Nuveen Asset Management, Llc | $31,141.00 | 2.08% | 1.04M | -149,584 | -12.6% | 2024-12-31 |